1. Home
  2. KRYS vs GEF Comparison

KRYS vs GEF Comparison

Compare KRYS & GEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • GEF
  • Stock Information
  • Founded
  • KRYS 2015
  • GEF 1877
  • Country
  • KRYS United States
  • GEF United States
  • Employees
  • KRYS N/A
  • GEF N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • GEF
  • Sector
  • KRYS Health Care
  • GEF
  • Exchange
  • KRYS Nasdaq
  • GEF Nasdaq
  • Market Cap
  • KRYS 3.8B
  • GEF 3.8B
  • IPO Year
  • KRYS 2017
  • GEF N/A
  • Fundamental
  • Price
  • KRYS $143.08
  • GEF $69.73
  • Analyst Decision
  • KRYS Strong Buy
  • GEF Buy
  • Analyst Count
  • KRYS 9
  • GEF 7
  • Target Price
  • KRYS $208.78
  • GEF $73.67
  • AVG Volume (30 Days)
  • KRYS 374.0K
  • GEF 314.1K
  • Earning Date
  • KRYS 08-04-2025
  • GEF 08-27-2025
  • Dividend Yield
  • KRYS N/A
  • GEF 3.10%
  • EPS Growth
  • KRYS 109.01
  • GEF N/A
  • EPS
  • KRYS 4.16
  • GEF 4.49
  • Revenue
  • KRYS $333,448,000.00
  • GEF $5,522,800,000.00
  • Revenue This Year
  • KRYS $44.05
  • GEF N/A
  • Revenue Next Year
  • KRYS $46.15
  • GEF $12.18
  • P/E Ratio
  • KRYS $34.43
  • GEF $15.54
  • Revenue Growth
  • KRYS 247.53
  • GEF 5.89
  • 52 Week Low
  • KRYS $122.80
  • GEF $48.23
  • 52 Week High
  • KRYS $219.34
  • GEF $73.16
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 57.50
  • GEF 70.87
  • Support Level
  • KRYS $135.86
  • GEF $64.47
  • Resistance Level
  • KRYS $143.44
  • GEF $70.05
  • Average True Range (ATR)
  • KRYS 5.15
  • GEF 1.63
  • MACD
  • KRYS 1.07
  • GEF 0.29
  • Stochastic Oscillator
  • KRYS 80.33
  • GEF 95.72

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About GEF Greif Inc.

Greif Inc is a producer of industrial packaging products and services with manufacturing facilities located in many countries. It offers a comprehensive line of rigid industrial packaging products, such as steel, fiber, and plastic drums, rigid intermediate bulk containers, closure systems for industrial packaging products, transit protection products, water bottles and remanufactured and reconditioned industrial containers, and services, such as container life cycle management, blending, filling, logistics, warehousing, and other packaging services. The company operates in three reportable business segments including Global Industrial Packaging, Paper Packaging and Services, and Land Management. It operates in USA, Europe, Middle East, Africa and Asia and Other Americas.

Share on Social Networks: